← Back to catalogue

Slendertone Arms

FDA UDI

Class II (US FDA UDI)

by Bio-Medical Research, Ltd.

Identity

Trade Name
Slendertone Arms FDA UDI
Generic Name
Transcutaneous electrical stimulation electrode, single-use FDA UDI
Device Name
Neuromuscular Electrical Stimulator intended to stimulate healthy muscles in order to improve or facilitate muscle performance of the triceps and biceps muscles. FDA UDI
Model / Reference
397 (390, X60) FDA UDI
Description
Neuromuscular Electrical Stimulator intended to stimulate healthy muscles in order to improve or facilitate muscle performance of the triceps and biceps muscles. FDA UDI

Identifiers

Catalog Number
0397-5044 FDA UDI
Primary DI / UDI-DI
15099058397011 FDA UDI
FDA Product Code
NGX FDA UDI
GMDN Term
Transcutaneous electrical stimulation electrode, single-use FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
890.5850 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Transcutaneous electrical stimulation electrode, single-usePhysical therapy transcutaneous neuromuscular electrical stimulation system

Slendertone Arms by Bio-Medical Research, Ltd. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Physical therapy transcutaneous neuromuscular electrical stimulation system.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 76a5f798-ae4f-4eb3-a8d7-77ef52da7655 34 fields · synced May 30, 2026